[Additional Experience with Medicinal Treatment of Trigeminal Nerve Pain]

Overview

Journal Schmerz

Date 2024 Aug 14

PMID 39141098

Authors

Wolfgang Liedtke

Affiliations

Soon will be listed here.

References

Watanabe K, Tubbs R, Satoh S, Zomorodi A, Liedtke W, Labidi M . Isolated Deep Ear Canal Pain: Possible Role of Auricular Branch of Vagus Nerve-Case Illustrations with Cadaveric Correlation. World Neurosurg. 2016; 96:293-301. DOI: 10.1016/j.wneu.2016.08.102. View

CreveCoeur T, Bethamcharla R, Gold M, Liedtke W, Sekula R . Letter to the Editor. Potential confounding variables when assessing racial disparities in outcomes after MVD for TN. J Neurosurg. 2023; 140(1):315-317. DOI: 10.3171/2023.6.JNS231346. View

Moore C, Gupta R, Jordt S, Chen Y, Liedtke W . Regulation of Pain and Itch by TRP Channels. Neurosci Bull. 2017; 34(1):120-142. PMC: 5799130. DOI: 10.1007/s12264-017-0200-8. View

Rodriguez E, Sakurai K, Xu J, Chen Y, Toda K, Zhao S . A craniofacial-specific monosynaptic circuit enables heightened affective pain. Nat Neurosci. 2017; 20(12):1734-1743. PMC: 5819335. DOI: 10.1038/s41593-017-0012-1. View

Yeo M, Chen Y, Jiang C, Chen G, Wang K, Chandra S . Repurposing cancer drugs identifies kenpaullone which ameliorates pathologic pain in preclinical models via normalization of inhibitory neurotransmission. Nat Commun. 2021; 12(1):6208. PMC: 8551327. DOI: 10.1038/s41467-021-26270-3. View

Sheets P, Heers C, Stoehr T, Cummins T . Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J Pharmacol Exp Ther. 2008; 326(1):89-99. DOI: 10.1124/jpet.107.133413. View

Kanellopoulos A, Koenig J, Huang H, Pyrski M, Millet Q, Lolignier S . Mapping protein interactions of sodium channel Na1.7 using epitope-tagged gene-targeted mice. EMBO J. 2018; 37(3):427-445. PMC: 5793798. DOI: 10.15252/embj.201796692. View

Moutal A, Chew L, Yang X, Wang Y, Yeon S, Telemi E . (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Pain. 2016; 157(7):1448-1463. PMC: 4936788. DOI: 10.1097/j.pain.0000000000000555. View

Gomez-Arguelles J, Bermejo P, Lara M, Almajano J, Aragon E, Garcia Del Carrizo F . [Effectiveness of lacosamide in the treatment of refractory neuropathic pain: an open observational trial]. Rev Neurol. 2014; 59(7):289-93. View

10.

Munoz-Vendrell A, Tena-Cucala R, Campoy S, Garcia-Parra B, Prat J, Martinez-Yelamos S . Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases. Headache. 2023; 63(4):559-564. DOI: 10.1111/head.14505. View

11.

Munoz-Vendrell A, Teixidor S, Sala-Padro J, Campoy S, Huerta-Villanueva M . Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: A retrospective analysis of 144 cases. Cephalalgia. 2022; 42(10):1031-1038. PMC: 9442778. DOI: 10.1177/03331024221092435. View

12.

Kim P, Fishman M . Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. Curr Pain Headache Rep. 2020; 24(10):64. DOI: 10.1007/s11916-020-00898-0. View

13.

Younger J, Noor N, McCue R, Mackey S . Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013; 65(2):529-38. DOI: 10.1002/art.37734. View